Literature DB >> 19901712

Sjogren-larsson syndrome: case report and review of neurologic abnormalities and ichthyosis.

Lívia Almeida Dutra1, Camila Catherine Henriques de Aquino, Orlando Graziani Povoas Barsottini.   

Abstract

INTRODUCTION: Sjogren-Larsson syndrome (SLS) is characterized by the triad of ichthyosis, mental retardation, and spastic diplegia or quadriplegia. The hallmark of SLS is ichthyosis. We report a case and review the major differential diagnosis of SLS. CASE REPORT: A 21-year-old woman presented with seizures, mental retardation, spastic diplegia, and ichthyosis since birth. Computed tomography scan revealed hypodense areas in the periventricular white matter. Skin biopsy demonstrated a lamellar ichthyosis. These findings were compatible with SLS.
CONCLUSION: When ichthyosis is associated with spasticity and mental retardation, one should consider SLS. If hypogonadism, ataxia, retinitis, cardiomyopathy, or dwarfism is present, other diagnosis rather than SLS should be investigated.

Entities:  

Mesh:

Year:  2009        PMID: 19901712     DOI: 10.1097/NRL.0b013e3181906ff9

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  4 in total

1.  Sjogren-Larsson syndrome: A case report of a rare disease.

Authors:  S P Gupta; Amit Mittal; Baljeet Maini; Sanjeev Gupta
Journal:  Indian Dermatol Online J       Date:  2011-01

2.  Novel progressive acrodysostosis-like skeletal dysplasia, cerebellar atrophy, and ichthyosis.

Authors:  Harvy M Velasco; Ehsan Ullah; Angela M Martin; Robert B Hufnagel; Carlos E Prada
Journal:  Am J Med Genet A       Date:  2020-08-11       Impact factor: 2.578

3.  A rare case of Sjogren-Larsson syndrome with recurrent pneumonia and asthma.

Authors:  Azita Tavasoli; Shirin Sayyahfar; Babak Behnam
Journal:  Korean J Pediatr       Date:  2016-06-30

4.  High frequency of primary hereditary ichthyoses in the North-East region of Cairo, Egypt.

Authors:  Nermine El-Sayed; Neveen S Seifeldin; Christine K T Gobrial
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.